Document Detail

HIV-infected T cells are migratory vehicles for viral dissemination.
Jump to Full Text
MedLine Citation:
PMID:  22854780     Owner:  NLM     Status:  MEDLINE    
After host entry through mucosal surfaces, human immunodeficiency virus-1 (HIV-1) disseminates to lymphoid tissues to establish a generalized infection of the immune system. The mechanisms by which this virus spreads among permissive target cells locally during the early stages of transmission and systemically during subsequent dissemination are not known. In vitro studies suggest that the formation of virological synapses during stable contacts between infected and uninfected T cells greatly increases the efficiency of viral transfer. It is unclear, however, whether T-cell contacts are sufficiently stable in vivo to allow for functional synapse formation under the conditions of perpetual cell motility in epithelial and lymphoid tissues. Here, using multiphoton intravital microscopy, we examine the dynamic behaviour of HIV-infected T cells in the lymph nodes of humanized mice. We find that most productively infected T cells migrate robustly, resulting in their even distribution throughout the lymph node cortex. A subset of infected cells formed multinucleated syncytia through HIV envelope-dependent cell fusion. Both uncoordinated motility of syncytia and adhesion to CD4(+) lymph node cells led to the formation of long membrane tethers, increasing cell lengths to up to ten times that of migrating uninfected T cells. Blocking the egress of migratory T cells from the lymph nodes into efferent lymph vessels, and thus interrupting T-cell recirculation, limited HIV dissemination and strongly reduced plasma viraemia. Thus, we have found that HIV-infected T cells are motile, form syncytia and establish tethering interactions that may facilitate cell-to-cell transmission through virological synapses. Migration of T cells in lymph nodes therefore spreads infection locally, whereas their recirculation through tissues is important for efficient systemic viral spread, suggesting new molecular targets to antagonize HIV infection.
Thomas T Murooka; Maud Deruaz; Francesco Marangoni; Vladimir D Vrbanac; Edward Seung; Ulrich H von Andrian; Andrew M Tager; Andrew D Luster; Thorsten R Mempel
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2012-08-01
Journal Detail:
Title:  Nature     Volume:  490     ISSN:  1476-4687     ISO Abbreviation:  Nature     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-12     Completed Date:  2012-11-06     Revised Date:  2014-11-13    
Medline Journal Info:
Nlm Unique ID:  0410462     Medline TA:  Nature     Country:  England    
Other Details:
Languages:  eng     Pagination:  283-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
CD4-Positive T-Lymphocytes / virology*
Cell Movement
Cells, Cultured
Disease Models, Animal
Giant Cells
HIV / immunology*
HIV Infections / immunology*,  transmission,  virology*
Lymph Nodes / virology
Mice, Inbred NOD
Mice, SCID
Mice, Transgenic
Grant Support
Comment In:
Nat Rev Immunol. 2012 Sep;12(9):620-1   [PMID:  22918462 ]
Nat Rev Microbiol. 2012 Oct;10(10):673   [PMID:  22903165 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Full Text
Journal Information
Journal ID (nlm-journal-id): 0410462
Journal ID (pubmed-jr-id): 6011
Journal ID (nlm-ta): Nature
Journal ID (iso-abbrev): Nature
ISSN: 0028-0836
ISSN: 1476-4687
Article Information
Download PDF

nihms-submitted publication date: Day: 18 Month: 7 Year: 2012
Electronic publication date: Day: 01 Month: 8 Year: 2012
Print publication date: Day: 11 Month: 10 Year: 2012
pmc-release publication date: Day: 11 Month: 4 Year: 2013
Volume: 490 Issue: 7419
First Page: 283 Last Page: 287
PubMed Id: 22854780
ID: 3470742
DOI: 10.1038/nature11398
ID: NIHMS394322

HIV-infected T cells are migratory vehicles for viral dissemination
Thomas T. Murooka1
Maud Deruaz1
Francesco Marangoni1
Vladimir D. Vrbanac1
Edward Seung1
Ulrich H. von Andrian2
Andrew M. Tager1
Andrew D. Luster1
Thorsten R. Mempel1*
1The Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, MA
2Immune Disease Institute and Department of Microbiology and Immunology, Harvard Medical School, Boston, USA
*Correspondence should be addressed to: T.R.M. (

In HIV infection, lymph nodes are important sites of viral replication, where the high local density of CD4+ T cells and other target cells may favor cell contact-mediated viral spread. Since infection of BLT (Bone marrow/Liver/Thymus) humanized mice5 replicates many hallmarks of infection in humans68, we utilized this small animal model (Supplementary Fig. 1a) and intravital microscopy to investigate the dynamic behavior of HIV-infected T cells in the stromal environment of LNs.

We first sought to validate this mouse model for studying the effects of HIV infection on T cell migration. The presence of both naïve and memory human CD4+ and CD8+ T cells in secondary lymphoid organs (SLOs) of BLT mice demonstrates their general capacity to home to these sites (Fig. 1a). To determine the efficiency of this trafficking process we infused BLT mice with mixtures of isogenic CD4+ human T cells and murine CD4+ T cells from OT-II TCR transgenic mice. Over the course of 18 hours, human T cells were half as efficient as murine cells at entering peripheral LNs, while their accumulation in mesenteric LNs was equivalent (Fig. 1b). Thus, the interspecies molecular interactions between selectins, chemokine receptors, and integrins on human T cells with their ligands expressed on murine LN high endothelial venules9 are collectively functional, albeit at a slightly reduced level.

Upon entering LNs, T cell migration is guided by their sensing of chemokines10 and interactions with the paracortical fibroblastic reticulum11, which is well preserved in BLT mice (Supplementary Fig. 1b). We compared the migration of human and murine T cells in BLT LNs by MP-IVM. Intravenously infused human and murine cells distributed similarly in the LN cortex, were indistinguishable in various aspects of motility (Fig. 1c–e, Supplementary Fig. 1c–e and Video 1), and in this regard each resembled murine T cells in fully murine LNs4. We concluded that human T cell homing to LNs was efficient and their migration within LNs of BLT mice was, using mouse T cells as reference, normal, allowing us to study the impact of HIV infection on this basic process.

In order to seed LNs with HIV we injected BLT mice in the footpad with GFP-expressing, CCR5-using HIV (called ‘HIV-GFP’ here), which we derived by replacing the V3 loop region of env in the originally CXCR4-tropic NL4-3-IRES-GFP12 with that of HIV BaL (Supplementary Fig. 2a, b). Subcutaneous infection reliably produced high levels of plasma viremia (Fig. 2a) and systemic infection (Supplementary Fig. 2c). However, between two and six days after footpad infection, we detected GFP+ cells only in the ipsilateral popliteal, but not remote LNs, indicating that the infection was initially contained in the primary draining LNs (Fig. 2b, Supplementary Fig. 2e). The vast majority of these infected cells were resting (SSClow), antigen-experienced (CD45RO+) T cells with variable expression of CCR7. By day 2 some loss of CD4 cell surface expression was apparent13, but this was much more pronounced at day 6, when cells had also downregulated MHC I. (Supplementary Fig. 2e).

To investigate the localization of HIV-infected T cells in LNs early after footpad infection, we analyzed draining LNs by MP-IVM two days after virus inoculation. At this time, GFP+ cells were evenly distributed up to several hundred μm away from the subcapsular sinus (SCS), implying that lymph-borne HIV arriving in the LN SCS has efficient means of infiltrating the LN cortex (Fig. 2c). In time-lapse recordings it became apparent that GFP-expressing LN cells migrated at average 2D velocities of ~7 μm/min and were thus robustly motile, suggesting that their motility facilitated the local dissemination of HIV infection in LNs (Fig. 2d–f, Supplementary Video 2). Since the majority of infected T cells in early SIV-infection of macaques are resting memory T cells14, and the majority of infected LN cells in our BLT mouse model resembled antigen-experienced T cells (Fig. 2b), we compared their motility to that of in vitro-generated, GFP-expressing, central memory-like CD4+ human T cells (“Tcm”) that express CD62L and CCR7 and migrate to LNs after adoptive transfer (Supplementary Fig. 3a–c). Compared to this reference population, the motility of HIV-infected LN cells was reduced (Fig. 2e, f, Supplementary Fig. 3d, e, and Videos 2, 3), which may reflect the ability of HIV to interfere with cytoskeletal processes involved in cell migration15, 16.

While most infected LN cells resembled antigen-experienced T cell in terms of motility as well as size and shape, a subpopulation (10–20%) of cells stood out by their unusually elongated, thin, and sometimes branched trailing edges. These cells reached average skeletal lengths of at times more than 100 μm, while Tcm rarely exceeded 20 μm (Fig. 2g, h, Supplementary Videos 2–4). When we tracked skeletal lengths in individual cells along with their motility, we noted that some of the elongated cells continued to be motile (Fig. 2i). Similar results were obtained with SF162R317, a GFP-expressing strain derived from the primary R5-tropic clone SF162 (Supplementary Fig. 4 and Video 5).

Since it was possible that our flow cytometry analysis failed to detect these elongated cells (Fig. 2b), and that these were in fact not T cells, we wanted to determine unambiguously whether HIV-infected T cells could acquire such unusual morphological characteristics in vivo. Therefore, we adopted a co-culture method18 to efficiently infect Tcm with HIV-GFP in vitro (Fig. 3a), and transferred these cells into footpads of BLT mice, from where they migrated to draining popLNs. Recipient BLT mice were pre-treated with a cocktail of antiviral drugs6 to prevent infection of any host cells. Under these conditions, where the T cell identity of GFP+ cells in popLNs was known, we observed the same overall reduction in motility as well as a sub-population of abnormally elongated cells at a similar frequency as after in situ infection (Fig. 3b–dandSupplementary Video 6). Co-injection of uninfected Tcm also confirmed that these and HIV-infected T cells localized to the same regions of the LN and that decreased motility of HIV-infected cells did not result from their sequestration into a particular microenvironment (Supplementary Fig. 5 and Video 6).

The elongated morphology could result from infection of a T cell population that has an intrinsic propensity to adopt such shapes. Alternatively, HIV proteins might actively induce this phenotype. To distinguish between these two possibilities, we generated a CCR5-using, HIV-derived lentiviral vector that expresses GFP, but no HIV proteins in infected cells (Fig. 3e). Two days after footpad injection, a similar number of GFP+ cells were observed in draining LNs as after infection with HIV-GFP. However, these cells did not exhibit elongated shapes. They also migrated faster than HIV-GFP-infected LN cells and at similar speeds as Tcm (Fig. 3f–handSupplementary Video 7), further supporting that HIV induces migratory deceleration of infected cells. Thus, one or several HIV proteins induce the abnormal shapes and decreased motility of HIV-infected T cells.

During HIV assembly, which in migrating, polarized T cells takes place at the uropod19, the HIV Env glycoprotein is exposed on the cell surface and can trigger the formation of intercellular adhesive contacts with CD4-expressing cells in vitro2023. In the LN environment, where T cells are highly motile, such adhesive interactions could lead to abnormal uropod elongation through tethering of infected T cells to uninfected CD4+ LN cells. Supporting this scenario, we consistently observed stationary behavior of the trailing edges of migrating T cells, often followed by their rapid retraction, perhaps reflecting sudden release of tethered uropods (Supplementary Video 8). Alternatively, cellular elongations could also result from the formation of multinucleated syncytia, which also depends on the function of Env24. In order to test if either uropod tethering or syncytia formation are involved in the elongation of HIV-infected T cells we generated HIV-GFP ΔEnv, where large parts of Env, including the CD4-binding region, are not expressed (Supplementary Fig. 6a). When trans-complemented with an exogenous R5 HIV envelope, the virus was as infectious as HIV-GFP, but no secondary infections occurred, as expected, since infected cells expressed no functional Env (Supplementary Fig. 6b–d). Strikingly, the elongated phenotype of infected LN cells was completely lost in absence of functional Env (Fig. 4a–c and Supplementary Video 9). However, cells infected with HIV-GFP ΔEnv still migrated at reduced speeds (Fig. 4b, c), suggesting that HIV factors other than Env were largely responsible for decreased T cell motility. Cell elongation did not result from artificial interactions of Env with murine adhesion or extracellular matrix proteins, since it was not observed in HIV-infected Tcm migrating in LNs of non-humanized mice (Fig. 4dandSupplementary Fig. 7). To test whether interactions of Env specifically with CD4, or with other human ligands, such as the α4β7-integrin25, are involved in tethering, we mutated HIV-GFP to exchange a single critical amino acid in Env (D368R in the HBX2 consensus sequence) to abrogate CD4-binding26 (Supplementary Fig. 8). Cells infected with HIV-GFP D368R showed the same loss of cell elongation as observed after deletion of Env (Fig. 4d).

To examine if some of the highly elongated T cells are part of multinucleated syncytia, we analyzed infected BLT LNs by histology. However, while we did find GFP-expressing cells with multiple nuclei (not shown), we were unable to visualize the elaborate tethers observed by MP-IVM in thick tissue sections, which may explain in part why these presumably highly labile structures have not been observed in human histological tissue samples. Therefore, we generated HIV-nGFP, in which GFP is targeted to cell nuclei through addition of a nuclear localization signal (Supplementary Fig. 9). When we infected BLT mice with this strain, we observed by MP-IVM that the vast majority of elongated LN cells were multinucleated syncytia that, given the involvement of Env, most likely developed through cell fusion (Fig. 4e, f). These syncytia frequently migrated with their tightly clustered nuclei moving in a coordinated fashion, but intermittently dispersed so that individual nuclei moved in different directions, yet remained connected by long membrane tethers (Supplementary Video 10). However, both fused and unfused cells also formed free-ending tethers, indicating that those were caused by adhesive interactions with non-visualized CD4+ cells (Supplementary Video 11). While similar membrane tethers, such as nanotubes, can also form between T cells in vitro in the absence of viral infection27, Env proteins of HIV and other retroviruses have been shown to facilitate their formation23, 28. Adhesive tethers may promote cell-to-cell viral transfer through VSs, or may reflect the initiation of cell fusion, or both.

Movement of free HIV virions within and between tissues is likely restricted by the limits of diffusion, by anatomical barriers, and by soluble immune factors, such as complement and natural antibody2. Allowing infected T cells to retain robust motility and to serve as migratory vehicles might therefore be a viral strategy for efficient local and systemic dissemination. If indeed long-range transport of HIV to distant tissues relies on the trafficking of infected cells during physiological T cell recirculation, then interfering with lymphocyte trafficking should limit systemic viral dissemination and reduce plasma viremia. To block T cell egress from LNs into efferent lymph vessels we treated BLT mice with the functional S1P receptor antagonist FTY720 (Fingolimod), which caused profound lymphopenia (Supplementary Fig. 10a).

Strikingly, in mice that received FTY720 starting at the time of infection with HIV-GFP, viral RNA in peripheral blood remained within or only slightly above background range (Fig. 4g), while the drug did not show antiviral activity in cell culture (Supplementary Fig. 10b). This result was confirmed with another R5-tropic strain, SF162R3 17 (Fig. 4h). Two months after infection, viral RNA was strongly reduced, yet not absent from remote lymphoid tissues of treated animals (Supplementary Fig. 10c), suggesting that FTY720 in the longer term did not fully prevent, but only limited dissemination within the lymphoid system. Accordingly, development of viremia after withdrawal of FTY720 after 8 weeks of treatment indicated that the release of T cells from lymphoid tissues rapidly initiated efficient systemic viral replication (Fig. 4h). Interestingly, we also observed a reduction in viral load in the draining LN in long-term treated animals (Supplementary Fig. 10c). This may reflect local depletion of HIV T cell targets, but could also indicate that FTY720 treatment reduces viral replication through a general perturbation of T cell homeostasis or through delayed, direct antiviral activity, independently of its effect on the trafficking of HIV-infected T cells. However, FTY720 did not affect viremia in mice with pre-established infection (Fig. 4i), similar to what was observed in SHIV infection of macaques29. While we cannot rule out other direct or indirect effects of FTY720 on viral replication, the observation that HIV infection is limited and high-level viraemia prevented by interfering with T-cell recirculation before, but not after systemic viral dissemination, suggests an important role for the trafficking of infected, migratory T cells in the efficient transport of HIV from draining to remote lymphoid tissues.

In summary, we find that HIV induces a partial reduction in the motility of infected T cells, as well as their tethering to and fusion with CD4+ immune cells in LNs. This may reflect the need for HIV to tune T cell migratory and interactive behavior in order to meet two opposing requirements: The use of motile cells as vehicles to disseminate within and between tissues, which inherently involves short-lived cell contacts; and the formation of VSs and, possibly, syncytia, for cell-to-cell spread, which likely requires longer-lasting cell contacts. Reduced motility of infected T cells might favor the formation and maintenance of tethering contacts with potential HIV target cells, while still allowing for efficient trafficking to distant tissues.

BLT humanized mice

Sublethally irradiated, female NOD/SCID mice were transplanted under the kidney capsule with 1mm3 fragments of human fetal liver and thymus, and injected i.v. with 1–5 × 105 purified CD34+ human fetal liver cells. After 18–20 weeks, healthy mice with >50% human lymphoid reconstitution in peripheral blood were used for experiments within 6 weeks. In experiments that did not require popliteal LNs, NOD/SCID x γc−/− (NSG) mice were used as graft recipients.

HIV reporter strains

The CCR5-using, GFP-expressing virus NL4-3 IRES-GFP R5 (‘HIV-GFP’) was constructed from pBR-NL4-3-IRES-GFP-nef+12 by replacing the V3 loop region of env with the corresponding sequence from the R5 clone BaL. HIV-GFP ΔEnv and HIV-GFP D368R were generated by site-directed mutagenesis. To produce infectious HIV-GFP ΔEnv and HIV-GFP D368R, the BaL Env was trans-complemented using a helper plasmid during virus production. HIV-nGFP was generated by inserting the SV40 nuclear localization sequence N-terminal of GFP in HIV-GFP. The lentiviral vector pHAGE-CMV-GFP was packaged with the R5 Env and standard helper plasmids to produce the CCR5-using ‘R5 LV-GFP’, which expresses no HIV proteins in infected cells.

MP-IVM of HIV-infected cells in lymph nodes

For in situ-infection of LN cells, BLT mice were injected into the footpad with 0.5 – 1.5 × 105 infectious units of recombinant HIV or R5 LV-GFP. 48 hours later, the draining popLNs were imaged by MP-IVM, as described4. Alternatively, HIV-GFP-infected Tcm were injected into the footpads of BLT mice pretreated with antiretroviral drugs, and imaged by MP-IVM 12 hours later.

BLT humanized mice

Female NOD/SCID (NS) and NOD/SCID x γc−/− (NSG) mice were purchased from Jackson Laboratories and reconstituted at age 6–8 weeks with human immune systems as previously described30. Briefly, mice were conditioned with sublethal (2 Gy) whole-body irradiation and transplanted with 1 mm3 fragments of human fetal thymus and liver (17 to 19 weeks of gestational age, from Advanced Bioscience Resources) under the kidney capsule. CD34+ cells were isolated from human fetal liver using anti-CD34 microbeads (Miltenyi Biotec) and injected intravenously (1 – 5 × 104 cells/mouse) within 6 hours of surgery to create “BLT” (Bone marrow, Liver and Thymus) mice. Mice were monitored for human hematopoietic reconstitution at 14 and 18 weeks post-transplantation. High lymphoid reconstitution in peripheral blood (>25% lymphocytes in PBL, >50% human lymphocytes, >40% T cells among lymphocytes) correlated with optimal lymph node reconstitution suitable for intravital imaging (typically at 18–20 weeks). NS mice were used for all experiments involving footpad injection of HIV or cells and analysis (e.g. by MP-IVM) of draining popliteal LNs. NSG mice, which lack popliteal, but possess cervical LNs, were used for long-term experiments involving FTY720 treatment.

OT-II TCR transgenic mice were obtained from Jackson Laboratories and bred in house. All experiments were performed in accordance to the rules and regulations of the Center of Comparative Medicine (CCM) and approved by the MGH Institutional Animal Care and Use Committee (IACUC) and the Harvard Medical Area Standing Committee on Animals.

Plasmids and virus production

The proviral plasmid pBR-NL43-IRES-EGFP-nef+ (pIeG-nef+)31 was obtained from the NIH AIDS Research & Reference Reagent Program (ARRRP, Catalog #11349). The V3 loop of env was modified to resemble that of HIV BaL and confer R5-tropism, as previously described32. Briefly, a commercial kit (Stratagene) and primers 5′-cccaacaacaatacaagaaaaagtatacatataggaccaggcagagcattatat acaacaggagaaataataggagatataagacaagcacattgtaacattag-3′ and 5′-ctaatgttacaatgtgcttgtc ttatatctcctattatttctcctgttgtatataatgctctgcctggtcctatatgtatactttttcttgtattgttgttggg-3′ were used according to the manufacturer’s protocol to mutagenize pIeG-nef+ and obtain pIeG-nef+ R5. The non-GFP-expressing parental plasmid, pNL4-3, was similarly mutagenized to obtain pNL4-3 R5. Infectious virus generated form pIeG-nef+ R5 and pNL4-3 R5 are called ‘HIV-GFP’ and ‘HIV’ for short.

The pSVIIIexE7-ADA env-expressing vector (kindly provided by Dr. J. Sodroski) was modified by restriction cloning to express env from pIeG-nef+ R5 using KpnI and BamHI restriction sites to obtain pSVIIIexE7-BaL.

To construct an env-deleted reporter construct, pIeG-nef+ R5 was digested with PsiI (nucleotide 6865 and 7599) and re-ligated. The resulting frameshift mutation introduced a pre-mature stop codon while the RRE remained intact. The new plasmid pIeG-nef+ Δenv was packaged with pSVIIIexE7-BaL to obtain HIV-GFP ΔEnv.

To construct the CD4-binding-deficient reporter virus HIV-GFP D368R, site-directed mutagenesis of pIeG-nef+ R5 was performed using primers 5′-gcaatcctcaggagggcgcccagaaattgtaacg-3′ and 5′-cgttacaatttctgggcgccctcctgaggattgc-3′ (Stratagene). Successful mutagenesis was confirmed by DNA sequencing. HIV-GFP D368R was packaged with pSVIIIexE7-BaL to obtain single-round infectious viral supernatant.

The lentiviral vector construct pHAGE-CMV-GFP is a modification of a construct originally developed in the laboratory of Dr. Richard C. Mulligan at Harvard Medical School33. pHAGE-CMV-GFP was packaged with standard helper plasmids and pSVIIIexE7-BaL to obtain the non-replicating, R5-using vector R5 LV-GFP. To construct the vector pHAGE-NLS-Cerulean, first GFP was replaced in pHAGE-CMV-GFP with Cerulean using restriction enzyme sites NcoI and XmaI to obtain pHAGE-CMV-Cerulean. Then, the complementary primers 5′-agccccatggctccaaaaaagaagagaaaggtaggcgccatggct-3′ and 5′-agccatggcgcctacctttctcttcttttttggagccatgggct-3′ were annealed, digested with NcoI and inserted into pHAGE-CMV-Cerulean, placing the NLS peptide of SV40 immediately upstream of GFP. The same cloning strategy was used to construct HIV-nGFP from HIV-GFP.

Dr. Amanda Brown at Johns Hopkins University School of Medicine kindly provided pSF162R3.

All HIV and lentiviral stocks were produced by transfecting HEK293T cells using Lipofectamine 2000 (Invitrogen). Viral supernatants were clarified through a 0.22μm filter and centrifuged at 90,000 × g for 2 hours using an SW28Ti rotor (Beckman Coulter) over a 20% sucrose cushion. Viral stocks were titrated using MAGI.CCR5 cells and expressed as bfu/mL (blue focus units/mL) as described previously34.


Human and murine CD4+ T cells were purified from uninfected BLT and OT-II mice, respectively, by negative immuno-magnetic selection (Miltenyl Biotec), and labeled with 2 μM Celltracker green (CMFDA) or 10 μM Celltracker blue (CMAC, both from Invitrogen) before adoptive transfer into BLT mice (see below).

Human CD4+ central memory-like T cells (Tcm) were generated as described previously with slight modifications35. Briefly, CD4+ T cells were isolated from spleen and LNs of BLT mice by positive immuno-magnetic selection using CD4 microbeads (Miltenyi Biotec) to purities consistently above 95%. Cells were activated by adding Dynabeads coated with anti-human CD3ε/CD28 antibody (3:1 bead:cell ratio, Invitrogen) for 2 days in RPMI 1640 supplemented with 10% FCS (Atlanta Biologicals), 2 mM L-glutamine (Gibco), 1mM sodium pyruvate and 10mM HEPES (Mediatech). After 2 days, cells were washed and cultured for another 6–8 days in medium containing 50 IU/mL human rIL-2 (R&D Systems), keeping cell density close to 5 × 105 cells/mL. Cells were used for all experiments between days 8 and 10.

To infect Tcm with HIV-GFP with high efficiency, we used a modified co-culture method36. Briefly, 2 × 106 MAGI.CCR5 cells were transfected with 10μg of pIeG-nef+ R5 and 24 hours later T cells were added to the confluent layer of virus-producing cells. Two days later, T cells were collected by Ficoll gradient centrifugation and washed three times before injection into BLT mice. Since with this approach we could only generate a limiting number of HIV-infected Tcm, we injected these into footpads for initially selective and efficient delivery to draining LNs,37 since upon i.v. injection cells distributed to all secondary lymphoid tissue and accumulated in only smaller numbers in the popliteal LN under study. In some studies, HIV-infected Tcm were injected into the footpad of DHLMP2a mice38 depleted of NK cells through daily i.p. injections of 50μL anti-asialo GM1 antibody (Wako Chemicals Inc.) for 2 days.

To generate Tcm that were not infected with HIV-GFP, but expressed GFP for visualization by MP-IVM and comparison to HIV-GFP-infected cells, we transduced human T cells with VSV-G pseudotyped pHAGE-CMV-GFP on day 2 after activation. In some experiments, uninfected Tcm were stained for 15 min at 37 C with 10 μM CellTracker Orange (CMTMR, Invitrogen) before footpad or i.v. injection into BLT mice.

MAGI.CCR5 (Cat. #3522), U87.CD4 (Cat. #4031), U87.CD4.CCR5 (Cat. #4035), U87.CD4.CXCR4 (Cat. #4036) cells were all obtained from the ARRRP.

T cell homing studies

Isogenic human and murine OT-II CD4+ T cells were purified, differentially labeled with celltracker dyes, and injected i.v. into BLT mice. 18 hours later, flow cytometry was used to determine homing ratios based on the relative frequencies of human and mouse T cells injected and recovered in various tissues.

HIV infection of BLT mice

For analyses of HIV infection in popliteal LNs, BLT mice were injected into footpads with 5 × 104 – 1.5 × 105 infectious units of various HIV strains.

For longer-term studies on the effects of FTY720 treatment on the course of infection, 4 × 104 infectious units of HIV-GFP were injected into the cheek skin of NSG-derived BLT mice, which is drained by cervical LNs.

Plasma viremia

Mice were bled from the superficial temporal vein at indicated times and sera stored at −80°C. Viral RNA was isolated from 20–70 μL of plasma using the QIAamp viral RNA kit (Qiagen), reverse transcribed, and cDNA amplified by qPCR using SYBR green (Qiagen) on the Lightcycler 480-II (Roche). Plasma from uninfected BLT mice was used to determine the RT-PCR background signal, which was consistently higher than the background signal obtained with water.

Quantitation of tissue viral load

Mice were sacrificed at the specified days and lymph nodes and spleen were removed and stored in 200μL of RNAlater solution overnight (Ambion). Single-cell suspensions from tissues were obtained using the gentle MACS dissociator (Miltenyi Biotec) and RNA was extracted using a commercial kit (Qiagen). Quantification of viral RNA was performed as described above. Viral loads were normalized to total tissue RNA.

Pharmacological treatments

1 mg/kg BW FTY720 or vehicle was injected i.p every other day starting 1 hour before HIV infection of BLT mice to block T cell egress from LNs.39

100 mg/kg emtricitabine (FTC) and 150 mg/kg tenofovir disoproxil fumarate (TDF) were i.p. injected daily starting 2 days before footpad injection of HIV-infected Tcm to prevent infection of recipient BLT mice.

Intravital multiphoton microscopy and image analysis

BLT mice were anaesthetized and the popLNs microsurgically exposed for MP-IVM as previously described40. Imaging depth was typically 80–200 μm below the LN capsule. For multiphoton excitation and second harmonic generation, a MaiTai Ti:sapphire laser (Newport/Spectra-Physics) was tuned to between 830 and 920 nm for optimized excitation of the fluorescent probes used. For four-dimensional recordings of cell migration, stacks of 11 optical sections (512 × 512 pixels) with 4–5 μm z-spacing were acquired every 15 or 24 seconds to provide imaging volumes of 40 μm in depth. Emitted light and second harmonic signals were detected through 455/50 nm, 525/50 nm, 590/50 nm, and 665/65 band-pass filters with non-descanned detectors.

Data sets were transformed in Imaris 7.3.1 (Bitplane) to generate maximum intensity projections (MIPs) for export as Quicktime movies. Since automated 3D-tracking of cell migration through Imaris did not perform well on the complex shapes of elongated HIV-infected cells, we used automated or manual 2D-tracking of cell centroids for all motility analyses, which yielded slightly lower velocity measurements than 3D-tracking. 2D-cell lengths were measured in ImageJ as the longest path connecting front and end of unbranched cells or as the sum of path lengths of all branches of individual branched cells (“cell skeletal length”). Either instantaneous (frame-by-frame) cell lengths or average cell lengths for individual cell tracks are provided. Cell step and track parameters were further analyzed in Matlab (Mathworks).

All time-lapse sequences are accelerated 360x over real-time for display as Quicktime movies.

Flow cytometry

Phenotypic characterization of T cells was performed on an LSRII (Becton Dickinson), using FlowJo software (Tree Star) for analysis. Spleen and LNs were minced with fine forceps and passed through a 40 μm mesh to obtain single cell suspensions. Cells were washed, counted and stained with a panel of directly conjugated anti-human mAbs: CD3-APC/Cy7 (HIT3a), CD4-PE/Cy7 (OKT4), CCR7-APC (TG8), CD8-PerCP (RPA-T8), CD45RA-PE (HI100), CD45RO-PE (UCHL1), MHC-I-PerCP (W6/32), CCR5-PE (HEK/1/85a) and CD62L-Alexa488 (DREG-56) (Biolegend).

HIV-infected cells were fixed with 2% PFA after staining before analysis.


Frozen sections of BLT and C57BL/6 LNs previously fixed in paraformaldehyde were processed for histological analysis using standard techniques. Briefly, 20 μm frozen sections were permeabilized with Triton X-100, blocked with BSA and anti-CD16/32, and stained with polyclonal anti-desmin rabbit IgG (ab15200; abcam) and either mouse anti-human CD4 mouse IgG1 (clone RPA-T4, Biolegend) or FITC-anti-murine CD4 rat IgG2b (clone GK1.5, Biolegend) antibodies. Alexa Fluor 555-anti-rabbit IgG (A31572, Invitrogen) and FITC-anti mouse IgG (ab97022, Abcam) were used as secondary antibodies. Stained sections were embedded in VectaShield Hard set (Vector H-1400) and analyzed by multiphoton microscopy.

Statistical analysis

Unpaired Student’s t-test and Mann-Whitney U test were used for comparisons of data sets with normal or non-normal distribution, respectively, using Prism 5 (GraphPad). For the homing studies, one-sample t test was used for comparison to a hypothetical value of 1, corresponding to identical homing efficiency. When p-values were smaller than 0.05, differences were considered as significant.

Supplementary Material 1


FN2Supplementary Information is linked to the online version of the paper at

FN3Author contributions T.T.M., M.D. and T.R.M. performed all experiments. F.M. developed software for data analysis. E.S. and V.V. generated humanized mice. A.M.T., A.D.L. and U.H.v.A contributed to the overall study design. T.T.M. and T.R.M. designed the experiments and wrote the manuscript.

FN4Author information Reprints and permissions information is available at The authors declare no competing financial interests.

We thank Dr. J. Sodroski for the pSVIIIexE7 plasmid and Dr. A. Brown for HIVSF162R3; Drs. H.S. Shin as well as T. Tivey, K. Bankert and S. Tanno for technical assistance with the generation of humanized mice; Drs. A. Peixoto and D. Alvarez for management of the BL2+ multiphoton microscopy facility; Drs. A. Brass, T. Allen and T. Dudek at the Ragon Institute for assistance with virological techniques; and Mrs. N. Elpek, M. Byrne and A. Finzi for technical assistance. Funding for this study was through NIH grants P01 AI0178897, R56 AI097052, R01 CA150975, P30 AI060354, and a Platform Award from the Ragon Institute of MGH, MIT and Harvard. T.T.M. was supported by the MGH ECOR Tosteson Postdoctoral Fellowship Award and the NIH training grant T32 AI007387.

1. Haase AT. Early events in sexual transmission of HIV and SIV and opportunities for interventionsAnnu Rev Med6212739Year: 201121054171
2. Sattentau Q. Avoiding the void: cell-to-cell spread of human virusesNat Rev Microbiol681526Year: 200818923409
3. Gebhardt T,et al. Different patterns of peripheral migration by memory CD4+ and CD8+ T cellsNature4772169Year: 201121841802
4. Mempel TR,Henrickson SE,von Andrian UH. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phasesNature4271549Year: 200414712275
5. Melkus MW,et al. Humanized mice mount specific adaptive and innate immune responses to EBV and TSST-1Nat Med12131622Year: 200617057712
6. Denton PW,et al. Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT micePLoS Med5e16Year: 200818198941
7. Sun Z,et al. Intrarectal transmission, systemic infection, and CD4+ T cell depletion in humanized mice infected with HIV-1J Exp Med20470514Year: 200717389241
8. Brainard DM,et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT miceJ Virol83730521Year: 200919420076
9. von Andrian UH,Mempel TR. Homing and cellular traffic in lymph nodesNature Reviews Immunology3867878Year: 2003
10. Worbs T,Mempel TR,Bolter J,von Andrian UH,Forster R. CCR7 ligands stimulate the intranodal motility of T lymphocytes in vivoJ Exp Med20448995Year: 200717325198
11. Bajenoff M,et al. Stromal Cell Networks Regulate Lymphocyte Entry, Migration, and Territoriality in Lymph NodesImmunity259891001Year: 200617112751
12. Schindler M,Munch J,Kirchhoff F. Human immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanismJ Virol79548998Year: 200515827163
13. Chen BK,Gandhi RT,Baltimore D. CD4 down-modulation during infection of human T cells with human immunodeficiency virus type 1 involves independent activities of vpu, env, and nefJ Virol70604453Year: 19968709227
14. Zhang Z,et al. Sexual transmission and propagation of SIV and HIV in resting and activated CD4+ T cellsScience28613537Year: 199910558989
15. Stolp B,et al. HIV-1 Nef interferes with host cell motility by deregulation of CofilinCell Host Microbe617486Year: 200919683683
16. Nobile C,et al. HIV-1 Nef inhibits ruffles, induces filopodia, and modulates migration of infected lymphocytesJ Virol84228293Year: 201020015995
17. Brown A,Gartner S,Kawano T,Benoit N,Cheng-Mayer C. HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virusJ Leukoc Biol7867585Year: 200516000390
18. Casartelli N,et al. Tetherin restricts productive HIV-1 cell-to-cell transmissionPLoS Pathog6e1000955Year: 201020585562
19. Llewellyn GN,Hogue IB,Grover JR,Ono A. Nucleocapsid promotes localization of HIV-1 gag to uropods that participate in virological synapses between T cellsPLoS Pathog6e1001167Year: 201021060818
20. Jolly C,Kashefi K,Hollinshead M,Sattentau QJ. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapseJ Exp Med19928393Year: 200414734528
21. Chen P,Hubner W,Spinelli MA,Chen BK. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapsesJ Virol811258295Year: 200717728240
22. Hubner W,et al. Quantitative 3D video microscopy of HIV transfer across T cell virological synapsesScience32317437Year: 200919325119
23. Rudnicka D,et al. Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapsesJ Virol83623446Year: 200919369333
24. Sodroski J,Goh WC,Rosen C,Campbell K,Haseltine WA. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicityNature3224704Year: 19863016552
25. Arthos J,et al. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cellsNat Immunol93019Year: 200818264102
26. Thali M,et al. Effects of changes in gp120-CD4 binding affinity on human immunodeficiency virus type 1 envelope glycoprotein function and soluble CD4 sensitivityJ Virol65500712Year: 19911870209
27. Sowinski S,et al. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmissionNat Cell Biol102119Year: 200818193035
28. Sherer NM,et al. Retroviruses can establish filopodial bridges for efficient cell- to-cell transmissionNat Cell Biol93105Year: 200717293854
29. Kersh EN,et al. Evaluation of the lymphocyte trafficking drug FTY720 in SHIVSF162P3-infected rhesus macaquesJ Antimicrob Chemother6375862Year: 200919218272
30. Brainard DM,et al. Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT miceJournal of Virology83730521Year: 200919420076
31. Schindler M,et al. Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef allelesJ Virol771054856Year: 200312970439
32. Hwang SS,Boyle TJ,Lyerly HK,Cullen BR. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1Science253714Year: 19911905842
33. Mostoslavsky G,Fabian AJ,Rooney S,Alt FW,Mulligan RC. Complete correction of murine Artemis immunodeficiency by lentiviral vector- mediated gene transferProc Natl Acad Sci U S A1031640611Year: 200617062750
34. Pirounaki M,Heyden NA,Arens M,Ratner L. Rapid phenotypic drug susceptibility assay for HIV-1 with a CCR5 expressing indicator cell lineJ Virol Methods8515161Year: 200010716348
35. Bondanza A,et al. Suicide gene therapy of graft-versus-host disease induced by central memory human T lymphocytesBlood107182836Year: 200616293601
36. Casartelli N,et al. Tetherin restricts productive HIV-1 cell-to-cell transmissionPLoS Pathog6e1000955Year: 201020585562
37. Debes GF,et al. Chemokine receptor CCR7 required for T lymphocyte exit from peripheral tissuesNat Immunol688994Year: 200516116468
38. Casola S,et al. B cell receptor signal strength determines B cell fateNat Immunol531727Year: 200414758357
39. Schwab SR,Cyster JG. Finding a way out: lymphocyte egress from lymphoid organsNat Immunol81295301Year: 200718026082
40. Murooka TT,Mempel TR. Multiphoton intravital microscopy to study lymphocyte motility in lymph nodesMethods Mol Biol75724757Year: 201221909917

Article Categories:
  • Article

Keywords: Human Immunodeficiency Virus (HIV)-1, Cell Migration, Lymph Node (LN), Multiphoton Intravital Microscopy (MP-IVM), Humanized Mice, T cell Trafficking.

Previous Document:  A III-V nanowire channel on silicon for high-performance vertical transistors.
Next Document:  A restricted cell population propagates glioblastoma growth after chemotherapy.